ANTIPLATELET DRUGS INTERVENTION ON POSTOPERATIVE INCIDENCE OF NO -RE-FLOW IN PATIENTS WITH CORONARY HEART DISEASE
10.3969/j.issn.1671-332X.2015.10.004
- VernacularTitle:抗血小板药物对冠心病患者介入术后无复流发生率的影响
- Author:
Yanhua LUO
- Publication Type:Journal Article
- Keywords:
Antiplatelet drugs;
Coronary heart disease;
Interventional therapy
- From:
Modern Hospital
2015;(10):14-15
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the influence of antiplatelet drugs in patients with coronary heart dis-ease after intervention incidence of no -reflow.Methods 180 cases of coronary artery interventional treatment of coronary heart disease and patients with no -reflow phenomenon as research subjects were randomly divided into ob-servation group and the control group of 90 cases.Observation group after intervention produce given tirofiban hydro-chloride treatment of no -reflow or slow reflow, and the control group received verapamil therapy .Results The final group was injected with drugs Coronary angiography showed TIMI 3 cases number than the control group , and the difference was statistically significant ( p<0.05);After treatment of coronary angiography for the first time , the last observation group was significantly higher level TMPG3, and the difference was statistically significant (p<0.05). Conclusion Compared with verapamil hydrochloride tirofiban in patients with coronary heart disease , intervention can effectively reduce postoperative incidence of no -reflow, which should be spreaded in clinical practice .
